Status:
RECRUITING
Prevent TB: Choice Architecture for TPT Delivery
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
University of Witwatersrand, South Africa
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV/AIDS
Tuberculosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Clinical guidelines and policies often fail to achieve high levels of delivery of intended clinical interventions. The difference in what the investigators know works and what is actually ...
Detailed Description
BACKGROUND HIV associated mortality and TB disease in LMIC: TB is the leading cause of death due to an infectious agent worldwide. Among PWH in low and middle income countries (LMIC), TB represents ...
Eligibility Criteria
Inclusion
- Adult (≥18 years old) patients initiating ART
- Adult (≥18 years old) patients already on ART and coming for ART re-prescribing
Exclusion
- None
Key Trial Info
Start Date :
September 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT04466488
Start Date
September 15 2021
End Date
November 1 2025
Last Update
January 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Perinatal HIV Research Unit
Soweto, Gauteng, South Africa, 1864